McKay D B, Schneider A S
J Pharmacol Exp Ther. 1984 Oct;231(1):102-8.
We have characterized the actions of taxol, a novel drug promoting microtubule formation, on 45Ca++ uptake and catecholamine release by isolated and cultured bovine adrenal chromaffin cells. The effects of taxol are compared with corresponding actions of vinblastine. We also have measured the effects of microtubule-active drugs on the dynamic pattern of release by means of column perifusion of isolated chromaffin cells. Taxol inhibits acetylcholine-stimulated catecholamine secretion (IC50: approximately 1 microM) and 45Ca++ uptake. The inhibitory effects of both taxol and vinblastine on secretion are rapid in onset (approximately 1 min) and reversible. Taxol and vinblastine (5 microM) exert little or no inhibitory effect on catecholamine secretion induced by 1) the nonreceptor mediated secretagogues K+, Ba++ or veratridine or by 2) the receptor-mediated secretagogues histamine or bradykinin. Similarly, taxol and vinblastine had no effect on K+-induced 45Ca++ uptake into chromaffin cells. The inhibitory effects of taxol and vinblastine during a secretory challenge are specific for cholinergic receptor-mediated 45Ca++ uptake and catecholamine release and prevent receptor-mediated membrane depolarization. These results do not support a role for microtubules either in the exocytosis event or in granule transport during an initial secretory challenge. The results would be consistent with either an interaction of microtubule protein with the acetylcholine receptor or a direct action of the drugs on the acetylcholine receptor.
我们已经研究了新型药物紫杉醇(一种促进微管形成的药物)对分离培养的牛肾上腺嗜铬细胞摄取45Ca++和释放儿茶酚胺的作用。将紫杉醇的作用与长春花碱的相应作用进行了比较。我们还通过分离嗜铬细胞的柱灌注法测量了微管活性药物对释放动态模式的影响。紫杉醇抑制乙酰胆碱刺激的儿茶酚胺分泌(IC50:约1 microM)和45Ca++摄取。紫杉醇和长春花碱对分泌的抑制作用起效迅速(约1分钟)且可逆。紫杉醇和长春花碱(5 microM)对以下因素诱导的儿茶酚胺分泌几乎没有抑制作用:1)非受体介导的促分泌剂K+、Ba++或藜芦定,或2)受体介导的促分泌剂组胺或缓激肽。同样,紫杉醇和长春花碱对K+诱导的嗜铬细胞摄取45Ca++也没有影响。在分泌刺激期间,紫杉醇和长春花碱的抑制作用对胆碱能受体介导的45Ca++摄取和儿茶酚胺释放具有特异性,并可防止受体介导的膜去极化。这些结果不支持微管在初始分泌刺激期间的胞吐事件或颗粒运输中起作用。这些结果与微管蛋白与乙酰胆碱受体的相互作用或药物对乙酰胆碱受体的直接作用一致。